Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that can result in high morbidity if not treated. This retrospective study aimed to evaluate the outcomes of rituximab treatment in a paediatric SLE cohort in Taiwan.

Subjects

autoimmune diseases; biological products; lupus erythematosus, systemic